1) Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintaub BD:Thyrotropin-secreting pituitary tumors. Endocr Rev 17:610-638, 1996
2) Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL:The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine(Baltimore)64:270-283, 1985
3) Courcoutsakis NA, Tatsi C, Patronas NJ, Lee CR, Prassopoulos PK, Stratakis CA:The complex of myxomas, spotty skin pigmentation and endocrine overactivity(Carney complex):imaging findings with clinical and pathological correlation. Insights Imaging 4:119-133, 2013
4) Horiguchi K, Yamada M, Umezawa R, Satoh T, Hashimoto K, Tosaka M, Yamada S, Mori M:Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas:a case showing a dramatic reduction in tumor size during short octreotide treatment. Endocr J 54:371-378, 2007
5) 金本巨哲,荒井宏司,中尾一和:下垂体機能亢進症TSH産生下垂体腫瘍.日本臨牀 新領域別症候群シリーズNo.1 内分泌症候群(第2版):125-128, 2006
6) 森 昌朋,山田正信:TSH産生腺腫のソマトスタチン受容体,TRH受容体及び甲状腺ホルモンβmRNAの発現:各種下垂体腺腫との比較.間脳下垂体機能障害に関する調査研究:76-79, 2007
7) 崎原 哲,森山貴子,照井 健,須田俊宏:Long-acting somatostatin analogが著効したTSH産生下垂体腫瘍の一例:日内分泌会誌84(Suppl):112-114, 2008
8) Stergiopoulos SG, Abu-Asab MS, Tsokos M, Stratakis CA:Pituitary pathology in Carney complex patients. Pituitary 7:73-82, 2004
9) Stratakis CA, Kirschner LS, Carney JA:Clinical and molecular features of the Carney complex:diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041-4046, 2001
10) 田中正巳,石井 均,山田正三,佐野壽昭:TRHに対しTSHが反応し,オクトレオチドで腫瘍縮小効果が著明であったTSH産生下垂体腺腫の1例.内科102:816-819, 2008
11) Watson JC, Stratakis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, Nguyen T, Carney JA, Oldfield EH:Neurosurgical implications of Carney complex. J Neurosurg 92:413-418, 2000
12) 吉原 愛,磯崎 収,肥塚直美,原田千絵,小野昌美,川俣貴一,堀 智勝,高野加寿恵:TSH産生腺腫におけるソマトスタチン受容体サブタイプ発現の解析.ホと臨床54:36-39, 2006